WAYNE, Pa.--(BUSINESS WIRE)--May 16, 2014--
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it
priced its offering of $250.0 million aggregate principal amount of
5.25% senior notes due 2024 (the “Notes”) at an issue price of 100% in a
private placement. The sale of the Notes is expected to close on May 21,
2014, subject to customary closing conditions.
The Notes will be guaranteed by each of Teleflex’s existing and future
wholly-owned domestic subsidiaries that is a guarantor or other obligor
under its revolving credit facility and by certain of Teleflex’s other
wholly-owned domestic subsidiaries.
Teleflex intends to use the net proceeds from the offering to repay
approximately $245.0 million of borrowings under its revolving credit
facility.
The Notes have not been registered under the Securities Act of 1933, as
amended (the “Securities Act”). The Notes may not be offered or sold
within the United States or to U.S. persons, except to “qualified
institutional buyers” in reliance on the exemption from registration
provided by Rule 144A and to non-U.S. persons in transactions outside
the United States in reliance on Regulation S. This announcement does
not constitute an offer to sell or the solicitation of an offer to buy
Notes in any jurisdiction in which such an offer or sale would be
unlawful.
ABOUT TELEFLEX INCORPORATED
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,400 people worldwide and serves
healthcare providers in more than 150 countries.
CAUTION CONCERNING FORWARD-LOOKING INFORMATION
All statements in this press release that are not historical facts
should be considered as “forward-looking statements.” Such statements
involve known and unknown risks, uncertainties and other factors that
may cause actual results, performance or achievements of the Company to
be materially different from any future results, performance or
achievements expressed or implied by the forward-looking statements.
Although we believe that our plans, intentions and expectations
reflected in, or suggested by, such forward looking statements are
reasonable, we can give no assurance that such plans, intentions, or
expectations will be achieved. Such risks, uncertainties and other
factors include, but are not limited to, (1) changes in business
relationships with and purchases by or from major customers or
suppliers, including delays or cancellations in shipments, (2) demand
for and market acceptance of new and existing products, (3) our ability
to integrate acquired businesses into our operations, realize planned
synergies and operate such businesses profitably in accordance with
expectations, (4) our ability to effectively execute our restructuring
programs, (5) projected savings falling short of targets, (6) the impact
of recently passed healthcare reform legislation and changes in
Medicare, Medicaid and third-party coverage and reimbursements, (7)
competitive market conditions and resulting effects on revenues and
pricing, (8) increases in raw material costs that cannot be recovered in
product pricing, (9) global economic factors, including currency
exchange rates, interest rates and sovereign debt issues, (10)
difficulties entering new markets and (11) general economic conditions.
Information about some of the known risks and uncertainties is included
in the “Risk Factors” section of the Company’s annual report on Form
10-K filed with the United States Securities and Exchange Commission
(the “SEC”) on February 24, 2014 and
quarterly report on Form 10-Q filed with the SEC on April 30, 2014 as
well as other filings with the SEC which can be obtained on the SEC’s
website at http://www.sec.gov.
We undertake no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events, changed circumstances or any other reason.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President of Investor Relations
610-948-2836